The availability of novel radionuclides plays a fundamental role in the development of
personalized nuclear medicine. In particular, there is growing interest in pairs formed by two …

Radiometals play a fundamental role in the development of personalized nuclear medicine.
In particular, copper radioisotopes are attracting increasing interest since they offer a varying …

The availability of novel medical radionuclides is a key point in the development of
personalised nuclear medicine. In particular, copper radioisotopes are attracting …

Abstract 44 Sc is a β+-emitter which has been extensively studied for nuclear medicine
applications. Its promising decay characteristics [t 1/2= 3.97 h, E β+= 632 keV (94.3%), E γ …

RadioNuclide Therapy (RNT) in nuclear medicine is a cancer treatment based on the
administration of radioactive substances that specifically target cancer cells in the patient …

Abstract 155 Tb is one of the most interesting radionuclides for theranostic applications. It is
suitable for SPECT imaging and it can be used as a true diagnostic partner of the …

Abstract 165 Er is a pure Auger-electron emitter with promising characteristics for
therapeutic applications in nuclear medicine. The short penetration path and high Linear …

The concept of theranostics in nuclear medicine is based on the use of a pair of
radioisotopes to label radiopharmaceuticals for both diagnosis and therapy and is essential …

Introduction: Targeted Radionuclide Therapy is used for the treatment of tumors in nuclear
medicine, while sparing healthy tissues. Its application to cancer treatment is expanding. In …

In the present work, the excitation functions for the proton-induced nuclear reactions on
natural zinc were measured in the energy range of 4–30 MeV using the well-established …